WHO expands options for HPV vaccination with Cecolin

FHS
October 7, 2024
10:37 am

WHO announced that a fourth WHO-prequalified human papillomavirus (HPV) vaccine product, Cecolin has been confirmed for use in a single-dose schedule. The

STP-938 by Step Pharma for Cutaneous T-Cell Lymphoma: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

February 8, 2024

Antibiotics disrupt protective gut mucus and heighten IBD risk

In a landmark study published today in Science Advances, Dr. Shai Bel and his research team at the Azrieli Faculty of Medicine of Bar-Ilan University

September 11, 2024

Early-stage healthcare startups are facing a funding cliff

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) The 2023 calendar year ends as it

November 29, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.